Myricx Bio
Developing a new class of ADCs based on NMT inhibition to treat cancer
36 employees · est. 2019 · London, United Kingdom
Leap Therapeutics is the older company (2011 vs 2019); Leap Therapeutics is the larger of the two.
2 signals in the last 90 days
Side-by-Side Comparison
| Metric | Leap Therapeutics | Myricx Bio |
|---|---|---|
| Founded | ||
| Founded | 2011 older | 2019 |
| Headquarters | ||
| Headquarters | Cambridge, United States | London, United Kingdom |
| Employees | ||
| Employees | 51 larger | 36 |
| Industry | ||
| Industry | Biotechnology, Life Sciences | Biotechnology, Health and Wellness, Life Sciences |
| Funding Stage | ||
| Funding Stage | Post Ipo Equity | Undisclosed |
| Total Funding | ||
| Total Funding | $266.50M | $1.59B |
| Funding Rounds | ||
| Funding Rounds | 10 | 3 |
| Services | ||
| Services | Not tracked yet | Discovery and development of novel ADCs, Preclinical efficacy and safety testing, Clinical team expansion and regulatory affairs |
| Target Customers | ||
| Target Customers | Not tracked yet | Oncologists, Pharmaceutical companies, Biotechnology partners, Research institutions |
| Taxonomy | ||
| Taxonomy | Biopharmaceutical, Clinical-stage, Cancer Research, Therapeutics, Oncology, Drug Development, Clinical Trials, Cancer Therapy, Innovation | Biotech, Antibody Drug Conjugates, ADC Development, N-Myristoyltransferase Inhibitors, NMT Inhibition, Oncology Treatment, Cytotoxic Payload Development, Small Molecule Drug Discovery, Cancer Therapy, Preclinical Efficacy, Drug Development Pipeline, Targeted Cancer Therapy, Novel Therapeutic Modalities, Solid Tumor Antigens |
| Website | ||
| Website | leaptx.com | myricxbio.com |
About Leap Therapeutics
### Leap Therapeutics: Acquiring Novel Therapeutics at the Leading Edge of Cancer Research Leap Therapeutics is a clinical-stage biopharmaceutical company that focuses on acquiring and developing novel therapeutics at the forefront of cancer research. Founded in 2011 and headquartered in the United...
About Myricx Bio
Myricx Bio is an innovative UK-based biotech company, established in 2019, with a mission to revolutionize cancer treatment through their novel technology. The company's tagline, "Developing a new class of ADCs based on NMT inhibition to treat cancer," reflects its pioneering approach in creating se...
Be first to know when either one moves
Funding rounds, hiring surges, leadership changes and stack switches at Leap Therapeutics and Myricx Bio — tracked continuously, sent the day they land.
Funding, hiring, leadership and stack changes at Leap Therapeutics and Myricx Bio — by email.
Frequently Asked Questions
Compare Leap Therapeutics with someone else
Start typing a company name or domain.